Target Price | $94.67 |
Price | $51.23 |
Potential |
84.79%
register free of charge
|
Number of Estimates | 9 |
9 Analysts have issued a price target PROCEPT BioRobotics 2026 .
The average PROCEPT BioRobotics target price is $94.67.
This is
84.79%
register free of charge
$105.00
104.96%
register free of charge
$77.00
50.30%
register free of charge
|
|
A rating was issued by 11 analysts: 9 Analysts recommend PROCEPT BioRobotics to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the PROCEPT BioRobotics stock has an average upside potential 2026 of
84.79%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 224.50 | 321.96 |
64.84% | 43.41% | |
EBITDA Margin | -40.70% | -12.13% |
47.39% | 70.20% | |
Net Margin | -42.65% | -25.32% |
52.61% | 40.64% |
11 Analysts have issued a sales forecast PROCEPT BioRobotics 2025 . The average PROCEPT BioRobotics sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an PROCEPT BioRobotics EBITDA forecast 2025. The average PROCEPT BioRobotics EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 PROCEPT BioRobotics Analysts have issued a net profit forecast 2025. The average PROCEPT BioRobotics net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.75 | -1.49 |
21.88% | 14.86% | |
P/E | negative | |
EV/Sales | 7.94 |
5 Analysts have issued a PROCEPT BioRobotics forecast for earnings per share. The average PROCEPT BioRobotics EPS is
This results in the following potential growth metrics and future valuations:
PROCEPT BioRobotics...
Analyst | Rating | Action | Date |
---|---|---|---|
Morgan Stanley |
Locked
➜
Locked
|
Locked | Feb 26 2025 |
Truist Securities |
Locked
➜
Locked
|
Locked | Feb 26 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Dec 03 2024 |
Morgan Stanley |
Locked
➜
Locked
|
Locked | Dec 02 2024 |
Jefferies |
Locked
➜
Locked
|
Locked | Nov 14 2024 |
Truist Securities |
Locked
➜
Locked
|
Locked | Oct 30 2024 |
Piper Sandler |
Locked
➜
Locked
|
Locked | Oct 08 2024 |
Analyst Rating | Date |
---|---|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Feb 26 2025 |
Locked
Truist Securities:
Locked
➜
Locked
|
Feb 26 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Dec 03 2024 |
Locked
Morgan Stanley:
Locked
➜
Locked
|
Dec 02 2024 |
Locked
Jefferies:
Locked
➜
Locked
|
Nov 14 2024 |
Locked
Truist Securities:
Locked
➜
Locked
|
Oct 30 2024 |
Locked
Piper Sandler:
Locked
➜
Locked
|
Oct 08 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.